Category: Edibles
-
Emerald Health (EMH.V) director stands down over security clearance issues
Buried in a news release discussing a shares-for-cash payment to an acquisition target, Emerald Health (EMH.V) stated Monday it is losing a board member over Health Canada security clearance concerns. Punit Dhillon is a self-described ‘life science thought leader‘ who likes to give TED Talks and has been involved with several biomedical companies on North…
-
TransCanna (TCAN.C) gets fruity in California cannabis market
On May 15, 2019 TransCanna (TCAN.C) announced an L.O.I with Tres Ojos Naturals, to acquire the branding asset package, Soldaze, which produces cannabis-infused fruit snacks in California. Before we get into the Soldaze deal, let’s review TransCanna’s 4-pronged business model: TransCanna provides investors access to a “closed loop ecosystem” built for consistency, reliability, and scale. TCAN…
-
Cresco Labs’ (CL.C) no-premium acquisition offer of Origin House (OH.C) is… alright
This morning, Chicago-based Cresco Labs (CL.C) announced it would be acquiring Origin House (OH.C) (formerly CannaRoyalty) in an all-stock deal worth CAN$1.1 billion. The offer comes in at CAN$12.68 per Origin House share. Origin House closed Friday at $12.05, which leaves the premium on the deal being less than amazing. In fact, the stock has…
-
Cannabis Life Sciences (CSE:CLSH.U): The US multi state operator value pick
I love it when the market is busy fighting over inflated market caps, because I’m a Moneyball guy. I like value, and while a lot of money has moved toward Canadian cannabis operators in recent years, the size of the market down south is only now starting to become clear. There’s still some value floating…
-
TGOD vs Wildflower: Underplaying your hand as opposed to overplaying it
Two news releases wafted past me yesterday that caused me to dig deeper than the words written on the page. This sometimes happens out of necessity – a company has to release news about a topic but can’t go into detail yet, or has bad news they don’t particularly want to run a highlighter over.…
-
Canadian LPs rush to supply Germany’s constrained marijuana market (TGOD.T) (ASNT.T) (CXXI.C) (CROP.C)
Germany’s medical marijuana market is lucrative, and Canadian LPs want in. Thankfully, Germany also wants Canadian companies to show them what’s up. Germany’s Shortage While Germany, the hottest cannabis market in the EU, has legalized medical marijuana, the country is in a nation-wide shortage of cannabis for a number of bureaucratic reasons. As a result, Germany’s…
-
Chemesis (CSI.C): The hard moving global cannabis venture that gets it, even if you don’t
In talking to Chemesis (CSI.C) CEO Edgar Montero, one thing becomes abundantly clear: You can go ahead and grow all the marijuana you want, and he won’t begrudge you your opportunities. He just doesn’t think that’s going to change the world, nor be bait for a bigger player looking for acquisitions, nor be a means…
-
The hemp shift: Livewell (LVWL.V), Heritage (CANN.C), Ascent (ASNT.C), Isodiol (ISOL.C) lead the CBD chase
If you want CBD, which is the stuff in cannabis that makes you healthier but that doesn’t get you stoned, hemp has as much of the stuff as commercial cannabis does. But hemp doesn’t attract mind boggling valuations on the public markets. On the TSX, 20k sq ft of licensed cannabis in a greenhouse in…
-
Plus Products (PLUS.C) California edibles deal goes public as TGOD spins off US asset
When I call up a CEO and hear their pitch, I mentally rank where that pitch sits in terms of intelligence, opportunity, trustworthiness, alongside all the pitches I’ve heard before. Like a Top Gear leaderboard, it’s hard to crack that list alongside such all-time greats as CannaRoyalty (CRZ.C), iAnthus (IAN.C), and Green Organic Dutchman (TGOD.T).…
-
Too professional: Pure Global (PURE.V) and the companies discounted because they’re actually building businesses
Had a conversation on the phone with Stephen Pynn, VP of Corporate Devs at Pure Global (PURE.V) this week that got me thinking. Pure has had an up and down run since landing on the public markets in July of this year. It ebbs and flows like the tides, never getting really beat up, but also…